One-step surgery with multipotent stem cells and Hyaluronan-based scaffold for the treatment of full-thickness chondral defects of the knee in patients older than 45 years - Summary - MDSpire
Advertisement
One-step surgery with multipotent stem cells and Hyaluronan-based scaffold for the treatment of full-thickness chondral defects of the knee in patients older than 45 years
To prospectively assess the impact of age and associated morbidities, such as specific comorbid conditions, on the treatment of ICRS grade 4 cartilage defects using BMAC and HYAFF®11 in patients older than 45 years.
Key Findings:
A high incidence of chondral lesions (60%) in patients aged 40-50 years undergoing knee arthroscopy, highlighting the need for targeted interventions.
BMAC and HYAFF®11 showed satisfactory short-term clinical results and tissue repair, indicating potential for broader application.
No clinical evidence suggests reduced cartilage repair potential of MSCs in aged patients, warranting further investigation.
Interpretation:
The use of BMAC with HYAFF®11 represents a promising one-step surgical option for treating cartilage defects in older patients, potentially overcoming limitations of traditional two-step procedures.
Limitations:
Small sample size of 20 patients in each group, which may limit the generalizability of the findings.
Lack of standardized MRI protocols across different facilities.
Conclusion:
BMAC and HYAFF®11 may provide an effective treatment for full-thickness chondral defects in patients over 45, warranting further studies for long-term outcomes to validate these findings.
